TC
SCPH

Tejara Capital’s scPharmaceuticals SCPH Stock Holding History

Tejara Capital’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-245,209
Closed -$1.39M – 72
2025
Q3 		$1.39M Sell
245,209
-252,521
-51% -$1.29M 0.73% 36
2025
Q2 		$1.9M Sell
497,730
-164,322
-25% -$510K 0.88% 35
2025
Q1 		$1.74M Buy
662,052
+49,202
+8% +$160K 0.67% 41
2024
Q4 		$2.17M Sell
612,850
-37,415
-6% -$143K 1.42% 19
2024
Q3 		$2.97M Sell
650,265
-54,477
-8% -$264K 1.41% 25
2024
Q2 		$3.07M Buy
704,742
+6,556
+0.9% +$28.8K 1.11% 32
2024
Q1 		$3.5M Sell
698,186
-59,585
-8% -$334K 1.29% 23
2023
Q4 		$4.75M Buy
757,771
+656,357
+647% +$3.76M 1.99% 19
2023
Q3 		$722K Buy
+101,414
New +$799K 0.41% 45

Tejara Capital's SCPH Position: Q4 2025 in Review

Tejara Capital sold out of scPharmaceuticals (SCPH) in Q4 2025, closing a stake of 245,209 shares — an estimated $1.39M sold.

Tejara Capital first reported a position in SCPH in Q3 2023 and held it in 9 quarters. The position peaked at $4.75M in Q4 2023. 0 funds tracked by Wall St. Rank hold SCPH as of Q4 2025.

  • Tejara Capital reported no remaining scPharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Tejara Capital sold 245,209 scPharmaceuticals shares in Q4 2025, an estimated $1.39M.
  • Tejara Capital first reported a position in scPharmaceuticals in Q3 2023 and held it in 9 quarters.
  • Tejara Capital's scPharmaceuticals position peaked at $4.75M in Q4 2023.
  • 0 funds tracked by Wall St. Rank held scPharmaceuticals as of Q4 2025.

Based on Tejara Capital's 13F filing for Q4 2025, filed 5 Feb 2026.